The MGAT4A mRNA expression levels quantified in WBC (Figure 2) revealed a 4.2-fold increase in mRNA levels in T2D subjects with respect to T2NB subjects (T2D subjects 1.19 ± 0.21 vs. T2NB subjects, 0.25 ± 0.06, P = 0.002). This evidence concerns the gene MGAT4A and type 2 diabetes mellitus.